Perform Another (Advanced) Search

1.  Study Posting (1819) Trial #108314, Sickle Cell Disease, Cincinnati, OH
...Posting (1819) Trial #108314, Sickle Cell Disease, Cincinnati, OH Trial Information Effectiveness of Hydroxyurea and Magnesium Pidolate Alone and in Combination in Hemoglobin SC Disease: A Phase II Trial What is ...
...purpose of this study? This research study is being done to see if taking hydroxyurea, magnesium (Mg) pidolate (a form of magnesium that is better tolerated than other forms of magnesium ...
View Page

2.  Newly Approved Drug Therapies (665) Nexium (esomeprazole magnesium), AstraZeneca,
...Newly Approved Drug Therapies (665) Nexium (esomeprazole magnesium), AstraZeneca, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Nexium (esomeprazole magnesium) Company: AstraZeneca Approval Status: Approved February 2001 Treatment Area: Duodenal ulcer disease, erosive esophagitis, and ...
View Page

3.  Study Posting (1819) Trial #85392, Sickle Cell Disease, Cincinnati, OH
...Study Posting (1819) Trial #85392, Sickle Cell Disease, Cincinnati, OH Trial Information Dipyridamole/Magnesium to Improve Sickle Cell Hydration What is the purpose of this study? The purpose of ...
...to determine the benefits as well as side effects of giving drugs called dipyridamole and magnesium to patients with sickle cell anemia (SCA). These drugs are given by mouth and will ...
View Page

4.  Study Posting (1819) Trial #84974, Sickle Cell Disease, Cincinnati, OH
...Study Posting (1819) Trial #84974, Sickle Cell Disease, Cincinnati, OH Trial Information Dipyridamole/Magnesium to Improve Sickle Cell Hydration What is the purpose of this study? The purpose of ...
...to determine the benefits as well as side effects of giving drugs called dipyridamole and magnesium to patients with sickle cell anemia (SCA). These drugs are given by mouth and will ...
View Page

5.  Newly Approved Drug Therapies (650) Pepcid Complete, Merck,
...stomach General Information Pepcid Complete combines an acid reducer (famotidine) with antacids (calcium carbonate and magnesium hydroxide) to relieve heartburn in two different ways: acid reducers decrease the production of new ...
...blockers inhibit histamine action, and therefore reduce gastric secretion or the amount of acid produced. Magnesium hydroxide and calcium carbonate are both antacids that function by neutralizing excess gastric acid. Additional ...
View Page

6.  CenterWatch Clinical Industry Provider Profile(4157), SpectraCell Laboratories, Houston, TX
...B2 (Riboflavin) • Vitamin B3 (Niacin) • Vitamin B5 (Pantothenate) • Vitamin B6 • Vitamin B12 • Biotin • Folate • Calcium • Magnesium • Selenium • Zinc • Coenzyme Q • Cysteine • Glutathione • Asparagine • Carnitine • Glutamine • Serine • Lipoic Acid • Oleic Acid • Choline ...
View Page

7.  CenterWatch Clinical Industry Provider Profile(1785), Worldwide Clinical Trials, King of Prussia, PA
...i.s (fraxiparine in ischemic syndrome) • hero-2 (hirulog in early reperfusion/occlusion 2) • magic (magnesium in coronary syndromes) WCT stays on the leading edge of education in the cardio field ...
View Page

8.  Newly Approved Drug Therapies (886) Arranon (nelarabine), GlaxoSmithKline,
...Hematological Toxicities (Anemia, Neutropenia, Thrombocyopenia, Leukopenia) • Hepatic Enzyme Elevations • Potassium Deficiencies • Vomitting • Calcium Deficiencies • Asthenia • Magnesium Deficiencies • Infection • Adult Population • Hematological Toxicities (Anemia, Neutropenia, Thrombocyopenia) • Fatigue • Nausea • Cough • Asthenia • Dyspnea • Petechiae ...
View Page

9.  CenterWatch: Gastroenterology Approved Drug Therapies
...the treatment of mild-to-moderate, active Crohn's disease, Approved October 2001 Nexium (esomeprazole magnesium) ; AstraZeneca; For the eradication of Helicobacter pylori, the healing of erosive esophagitis, and the treatment ...
View Page

10.  CenterWatch: List of Newly Approved Drug Thearapies
...the treatment of mild-to-moderate, active Crohn's disease, Approved October 2001 Nexium (esomeprazole magnesium) ; AstraZeneca; For the eradication of Helicobacter pylori, the healing of erosive esophagitis, and the treatment ...
View Page

11. Clinical Trial Results by Drug Names
...hematology and blood biochemistry did not identify any trends raising clinical concern. Decreases in serum magnesium, phosphate, and potassium concentrations led to marked laboratory abnormalities in 8, 7, 6 patients respectively ...
View Page

12.  Study Posting (5355) Trial #154833, Chronic Lymphocytic Leukemia, Plymouth, United Kingdom
...lower limit of normal in the central laboratory results at Screening. • Hypomagnesemia, as defined by magnesium below the lower limit of normal in the central laboratory results at Screening. • New York ...
View Page

13.  Study Posting (5355) Trial #154831, Chronic Lymphocytic Leukemia, London, United Kingdom
...lower limit of normal in the central laboratory results at Screening. • Hypomagnesemia, as defined by magnesium below the lower limit of normal in the central laboratory results at Screening. • New York ...
View Page

14.  Study Posting (5355) Trial #154832, Chronic Lymphocytic Leukemia, Exeter, United Kingdom
...lower limit of normal in the central laboratory results at Screening. • Hypomagnesemia, as defined by magnesium below the lower limit of normal in the central laboratory results at Screening. • New York ...
View Page

15.  Study Posting (5355) Trial #154834, Chronic Lymphocytic Leukemia, Bath, United Kingdom
...lower limit of normal in the central laboratory results at Screening. • Hypomagnesemia, as defined by magnesium below the lower limit of normal in the central laboratory results at Screening. • New York ...
View Page

16.  Study Posting (5355) Trial #154830, Chronic Lymphocytic Leukemia, Lodz, Poland
...lower limit of normal in the central laboratory results at Screening. • Hypomagnesemia, as defined by magnesium below the lower limit of normal in the central laboratory results at Screening. • New York ...
View Page

17.  Study Posting (5355) Trial #154829, Chronic Lymphocytic Leukemia, Gdansk, Poland
...lower limit of normal in the central laboratory results at Screening. • Hypomagnesemia, as defined by magnesium below the lower limit of normal in the central laboratory results at Screening. • New York ...
View Page

18.  Study Posting (5355) Trial #154828, Chronic Lymphocytic Leukemia, Bialystok, Poland
...lower limit of normal in the central laboratory results at Screening. • Hypomagnesemia, as defined by magnesium below the lower limit of normal in the central laboratory results at Screening. • New York ...
View Page

19.  Study Posting (5355) Trial #154825, Chronic Lymphocytic Leukemia, Strasbourg, France
...lower limit of normal in the central laboratory results at Screening. • Hypomagnesemia, as defined by magnesium below the lower limit of normal in the central laboratory results at Screening. • New York ...
View Page

20.  Study Posting (5355) Trial #154826, Chronic Lymphocytic Leukemia, Pierre Benite, France
...lower limit of normal in the central laboratory results at Screening. • Hypomagnesemia, as defined by magnesium below the lower limit of normal in the central laboratory results at Screening. • New York ...
View Page